newsfilter
← Latest News
PR Newswire·

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...